Compounds > masoprocol

masoprocol and Adenocarcinoma

masoprocol has been researched along with Adenocarcinoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fong, L; Formaker, CG; Friedlander, TW; Harzstark, AL; Huang, Y; Lin, AM; Mi, JT; Ryan, CJ; Small, EJ; Weinberg, VK1
Hofmanová, J; Kovaríková, M; Kozubík, A; Soucek, K1
Ashfaq, R; Bernstein, HS; Brock, M; Deasel, M; Dhara, S; Forastiere, A; Hansel, DE; Harmon, J; Huang, RC; Maitra, A; Montgomery, E; Shimada, Y; Washington, MK1
Allan, G; Campbell, MJ; Goldfine, ID; Hodges, L; Kerner, JA; Kushner, P; Maddux, BA; Shiry, L; Youngren, JF; Zavodovskaya, M1
Ban, H; Deyama, T; Hirano, N; Inada, K; Kumagai, T; Mizoshita, T; Nishibe, S; Takasu, S; Takenaka, Y; Tanaka, H; Tatematsu, M; Toyoda, T; Tsukamoto, T; Utsunomiya, H1
Dorr, RT; Lambert, JD; Meyers, RO; Timmermann, BN1
Dreyling, KW; Hoppe, U; Kozuschek, W; Morgenroth, K; Peskar, BA; Peskar, BM1
Fulton, AM; Heppner, GH1

Trials

1 trial(s) available for masoprocol and Adenocarcinoma

ArticleYear
A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer.
    Oncology reports, 2012, Volume: 27, Issue:1

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Humans; Male; Masoprocol; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Somatomedin

2012

Other Studies

7 other study(ies) available for masoprocol and Adenocarcinoma

ArticleYear
The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status.
    Differentiation; research in biological diversity, 2004, Volume: 72, Issue:1

    Topics: Adenocarcinoma; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Butyrates; Caspase 3; Caspases; Cell Cycle; Cell Differentiation; Cell Division; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Synergism; Flavanones; Flavonoids; HT29 Cells; Humans; Indomethacin; Isoenzymes; Lipoxygenase Inhibitors; Masoprocol; Membrane Proteins; Niflumic Acid; Prostaglandin-Endoperoxide Synthases; Tumor Necrosis Factor-alpha

2004
CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.
    The American journal of surgical pathology, 2005, Volume: 29, Issue:3

    Topics: Adenocarcinoma; Barrett Esophagus; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophagus; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Masoprocol; Precancerous Conditions; RNA, Messenger; RNA, Neoplasm; Tissue Array Analysis

2005
Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.
    Journal of cellular biochemistry, 2008, Feb-01, Volume: 103, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Division; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gefitinib; Humans; Insulin-Like Growth Factor Binding Protein 3; Masoprocol; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Quinazolines; Receptor, ErbB-2; Receptor, IGF Type 1; Selective Estrogen Receptor Modulators; Tamoxifen

2008
Inhibitory effect of nordihydroguaiaretic acid, a plant lignan, on Helicobacter pylori-associated gastric carcinogenesis in Mongolian gerbils.
    Cancer science, 2007, Volume: 98, Issue:11

    Topics: Adenocarcinoma; Animals; Cell Division; Disease Models, Animal; Furans; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Lignans; Male; Masoprocol; Plants; Polymerase Chain Reaction; Specific Pathogen-Free Organisms; Stomach Neoplasms; Urease

2007
tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo.
    Cancer letters, 2001, Sep-28, Volume: 171, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle; Colonic Neoplasms; DNA Replication; Female; Intracellular Membranes; Kidney; Liver; Lung Neoplasms; Male; Masoprocol; Melanoma; Melanoma, Experimental; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, SCID; Mitochondria; Neoplasm Transplantation; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001
Leukotriene synthesis by human gastrointestinal tissues.
    Biochimica et biophysica acta, 1986, Sep-12, Volume: 878, Issue:2

    Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Adenocarcinoma; Arachidonic Acid; Arachidonic Acids; Calcimycin; Chromatography, High Pressure Liquid; Colonic Neoplasms; Digestive System; Dinoprostone; Gastric Mucosa; Humans; In Vitro Techniques; Intestinal Mucosa; Leukotriene B4; Masoprocol; Muscle, Smooth; Prostaglandins E; Pyrazoles; SRS-A

1986
Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas.
    Cancer research, 1985, Volume: 45, Issue:10

    Topics: Adenocarcinoma; Animals; Catechols; Cell Line; Female; Indomethacin; Killer Cells, Natural; Male; Mammary Neoplasms, Experimental; Masoprocol; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Prostaglandins E

1985